The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

MEDICAL FRONTIERS - 36th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR)

Early Diagnosis and Treatment of Risk Factors for Osteoporosis Offer Major Opportunity Reduce Fracture Risk in China

Houston, Texas / September 12-15, 2014

Houston - Several factors explain the rapidly rising rate of fractures due to osteoporosis in China. One is the increasing proportion of the population over the age of 60. Another is the high rate of vitamin D deficiency, a nutrient...

PRIORITY PRESS - 74th Scientific Sessions of the American Diabetes Association (ADA)

Oral Therapies Realigned to Provide Improved Control and Reduced Risk in Type 2 Diabetes

San Francisco, California / June 13-17, 2014

San Francisco - New guidance for sustained glycemic control in type 2 diabetes mellitus (T2DM) has been derived from two studies of real-world therapy. Both studies, presented at the ADA, provided insight on long-term glycemic control in...

PRIORITY PRESS - 70th Annual Clinical and Scientific Conference of the Society of Obstetricians and Gynecologists of Canada (SOGC)

Update on HPV: Primary Care Providers Gatekeepers of Sexual Health for Mid-Life Women

Niagara Falls, Ontario / June 10-13, 2014

Niagara Falls, Ontario - Human papilloma virus (HPV) vaccines have been widely accepted as a primary prevention strategy in children and adolescents prior to their sexual debut before they are exposed to HPV. Less well accepted is the need...

PRIORITY PRESS - 73rd Scientific Sessions of the American Diabetes Association (ADA)

Clarity Grows on the Role of SGLT2 Inhibitors in Routine Control of Type 2 Diabetes

Chicago, Illinois / June 21-25, 2013

Chicago - The order in which oral agents are employed to control type 2 diabetes mellitus (T2DM) is under consideration as a result of the introduction of sodium glucose co-transporter 2 (SGLT2) inhibitors, based on clinical trial results...

PRIORITY PRESS - 73rd Scientific Sessions of the American Diabetes Association (ADA)

New Antidiabetic Medications Yield Flatter PK, More Predictable Blood Glucose Levels than Standards

Chicago, Illinois / June 21-25, 2013

Chicago - New therapeutic options for insulin-dependent diabetes are inching closer to the ideal of predictable blood glucose control over each 24-hour dosing period, according to large trial data presented at the ADA. Relative to the...

ABSTRACTS in PERSPECTIVE - Based on presentations from the 73rd Scientific Sessions of the American Diabetes Association (ADA)

Maturing Clinical Experience with SGLT2 Inhibitors Is Clarifying Clinical Applications

Chicago, Illinois / June 21-25, 2013

EDITORIAL OVERVIEW: Philip A. McFarlane, MD, PhD, FRCPC Division of NephrologySt. Michael’s HospitalUniversity of TorontoToronto, Ontario Jean-Francois Yale, MD, FRCPCMcGill University Health CentreMcGill UniversityMontreal,...

MEDICAL FRONTIERS - 4th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)

Novel Insulin-Independent Mechanism of Action Hits Triple Targets in Type 2 Diabetes

Barcelona, Spain / November 8-11, 2012

Barcelona - Management of type 2 diabetes mellitus (T2DM) implies more than achieving good glycemic control as most patients have comorbid conditions including high blood pressure (BP) and dyslipidemia. Most are overweight or obese as well....

MEDICAL FRONTIERS - 15th Annual Canadian Diabetes Association (CDA)/ Canadian Society of Endocrinology & Metabolism (CSEM) Professional Conference and Annual Meeting

Inhibiting Kidney Glucose Reabsorption: A Novel Insulin-independent Therapy in Type 2 Diabetes Mellitus

Vancouver, BC / October 10-13, 2012

Vancouver - New updated guidelines on the management of type 2 diabetes mellitus are expected early in 2013. A preview of the new guidelines indicates that glycemic targets may be relaxed in select patients and that the individualized...

PRIORITY PRESS - 48th Annual Meeting of the European Association for the Study of Diabetes

Targeting the Kidney in the Treatment of Diabetes and Associated Cardiovascular Risk Factors

Berlin, Germany / October 1-5, 2012

Berlin - Barriers to effective type 2 diabetes mellitus treatment include risk of hypoglycemia and weight gain, which may be associated with an increased risk of mortality and cardiovascular (CV) events. The new class of selective sodium...

PAGE 1 OF 6   1 2 3 4 5 6